Róisín Adams

Incorporating data from various trial designs into a mixed treatment comparison model

Susanne Schmitz, Róisín Adams, Cathal Walsh · Statistics in Medicine · 2013 · 122 citations

Public Health, Biostatistics, Causal Inference +15

The Expiry of Humira® Market Exclusivity and the Entry of Adalimumab Biosimilars in Europe: An Overview of Pricing and National Policy Measures

Evelien Moorkens, Brian Godman, Isabelle Huys et al. · Frontiers in Pharmacology · 2021 · 68 citations · Full text

Pharmacy, Pharmaceutical Policy, Pharmacology +17

Understanding the Relationship between the EQ-5D, SF-6D, HAQ and Disease Activity in Inflammatory Arthritis

Róisín Adams, Cathal Walsh, Douglas J. Veale et al. · PharmacoEconomics · 2010 · 59 citations

Medicine, Clinical Sciences, Inflammation +6

Relating health-related Quality of Life to disability progression in multiple sclerosis, using the 5-level EQ-5D

Emer Fogarty, Cathal Walsh, Róisín Adams et al. · Multiple Sclerosis Journal · 2013 · 40 citations · Full text

Pharmacy, Neurology, Disability Management +16

A Global eDelphi Exercise to Identify Core Domains and Domain Items for the Development of a Global Registry of Alopecia Areata Disease Severity and Treatment Safety (GRASS)

Dmitri Wall, Nekma Meah, Katherine York et al. · JAMA Dermatology · 2021 · 33 citations · Full text

Medicine, Biomedical Informatics, Dermatology +16